Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer R Verani

Showing results (61-70 of 164) with videos related to

Pageof 17
Sort By:
MMWR. Morbidity and Mortality Weekly Report|February 16, 2023
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023Katherine E Fleming-Dutra, Allison Avrich Ciesla, Lauren E Roper, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2022
Effectiveness of Coronavirus Disease 2019 (COVID-19) mRNA Vaccines Against Infection During an Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta (B.1.351) Variant in a Skilled Nursing Facility: Virginia, March-April 2021Heidi L Moline, Amelia Keaton, Whitney Rice, et al.
Vaccine|June 20, 2013
Critical issues in implementing a national integrated all-vaccine preventable disease surveillance systemTerri B Hyde, Jon K Andrus, Vance J Dietz, et al.
Vaccine|May 22, 2022
Development of effective messages to promote maternal immunization in KenyaPaula M Frew, Ines Gonzalez-Casanova, Nancy A Otieno, et al.
Plos Neglected Tropical Diseases|January 13, 2018
Multi-drug resistant non-typhoidal Salmonella associated with invasive disease in western KenyaAdam Akullian, Joel M Montgomery, Grace John-Stewart, et al.
Vaccine|December 5, 2025
Pneumococcal carriage among children and adults before and after a change from a three-dose 13-valent pneumococcal conjugate vaccine schedule without a booster to a two-dose schedule with a booster in Burkina FasoLana Childs, Robert Lamoussa Zoma, Issa Ouedraogo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 21, 2019
Indirect Effects of 10-Valent Pneumococcal Conjugate Vaccine Against Adult Pneumococcal Pneumonia in Rural Western KenyaGodfrey M Bigogo, Allan Audi, Joshua Auko, et al.
Implementation Science : IS|April 13, 2021
Decision-making process for introduction of maternal vaccines in Kenya, 2017-2018Nancy A Otieno, Fauzia A Malik, Stacy W Nganga, et al.
Obstetrics and Gynecology|May 3, 2014
Early-onset group B streptococcal disease in the United States: potential for further reductionJennifer R Verani, Nancy L Spina, Ruth Lynfield, et al.
Wellcome Open Research|April 11, 2022
Efficiency of transplacental transfer of respiratory syncytial virus (RSV) specific antibodies among pregnant women in KenyaJoyce U Nyiro, Elizabeth Bukusi, Dufton Mwaengo, et al.
Pageof 17

Showing results (61-70 of 164) with videos related to

Sort By:
Pageof 17
MMWR. Morbidity and Mortality Weekly Report|February 16, 2023
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023Katherine E Fleming-Dutra, Allison Avrich Ciesla, Lauren E Roper, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2022
Effectiveness of Coronavirus Disease 2019 (COVID-19) mRNA Vaccines Against Infection During an Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta (B.1.351) Variant in a Skilled Nursing Facility: Virginia, March-April 2021Heidi L Moline, Amelia Keaton, Whitney Rice, et al.
Vaccine|June 20, 2013
Critical issues in implementing a national integrated all-vaccine preventable disease surveillance systemTerri B Hyde, Jon K Andrus, Vance J Dietz, et al.
Vaccine|May 22, 2022
Development of effective messages to promote maternal immunization in KenyaPaula M Frew, Ines Gonzalez-Casanova, Nancy A Otieno, et al.
Plos Neglected Tropical Diseases|January 13, 2018
Multi-drug resistant non-typhoidal Salmonella associated with invasive disease in western KenyaAdam Akullian, Joel M Montgomery, Grace John-Stewart, et al.
Vaccine|December 5, 2025
Pneumococcal carriage among children and adults before and after a change from a three-dose 13-valent pneumococcal conjugate vaccine schedule without a booster to a two-dose schedule with a booster in Burkina FasoLana Childs, Robert Lamoussa Zoma, Issa Ouedraogo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 21, 2019
Indirect Effects of 10-Valent Pneumococcal Conjugate Vaccine Against Adult Pneumococcal Pneumonia in Rural Western KenyaGodfrey M Bigogo, Allan Audi, Joshua Auko, et al.
Implementation Science : IS|April 13, 2021
Decision-making process for introduction of maternal vaccines in Kenya, 2017-2018Nancy A Otieno, Fauzia A Malik, Stacy W Nganga, et al.
Obstetrics and Gynecology|May 3, 2014
Early-onset group B streptococcal disease in the United States: potential for further reductionJennifer R Verani, Nancy L Spina, Ruth Lynfield, et al.
Wellcome Open Research|April 11, 2022
Efficiency of transplacental transfer of respiratory syncytial virus (RSV) specific antibodies among pregnant women in KenyaJoyce U Nyiro, Elizabeth Bukusi, Dufton Mwaengo, et al.
Pageof 17